| Dr Jeffrey B Klein, DPM | |
|
26750 Providence Pkwy, Suite 130, Novi, MI 48374-1211 | |
| (248) 348-5300 | |
| (248) 348-5410 |
| Full Name | Dr Jeffrey B Klein |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 38 Years |
| Location | 26750 Providence Pkwy, Novi, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447357959 | NPI | - | NPPES |
| 2637307 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 5901400210 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mendelson Orthopedics Pc | 8426008368 | 62 |
News Archive
Results from a study carried out in identical and nonidentical twins suggests that a woman's risk for thin-ideal internalization may be genetic.
Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
The 2015 António Champalimaud Vision Award is given to three institutions that have developed a unique collaborative project to achieve the common goal of fighting blindness and poverty in Africa.
ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.
› Verified 1 days ago
| Provider Name | Mendelson Orthopedics Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720395205 PECOS PAC ID: 8426008368 Enrollment ID: O20050127000783 |
News Archive
Results from a study carried out in identical and nonidentical twins suggests that a woman's risk for thin-ideal internalization may be genetic.
Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
The 2015 António Champalimaud Vision Award is given to three institutions that have developed a unique collaborative project to achieve the common goal of fighting blindness and poverty in Africa.
ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.
› Verified 1 days ago
| Provider Name | Oakland Integrated Healthcare Network |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316214299 PECOS PAC ID: 9436313004 Enrollment ID: O20120611000523 |
News Archive
Results from a study carried out in identical and nonidentical twins suggests that a woman's risk for thin-ideal internalization may be genetic.
Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
The 2015 António Champalimaud Vision Award is given to three institutions that have developed a unique collaborative project to achieve the common goal of fighting blindness and poverty in Africa.
ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey B Klein, DPM 26750 Providence Pkwy, Suite 130, Novi, MI 48374-1211 Ph: (248) 348-5300 | Dr Jeffrey B Klein, DPM 26750 Providence Pkwy, Suite 130, Novi, MI 48374-1211 Ph: (248) 348-5300 |
News Archive
Results from a study carried out in identical and nonidentical twins suggests that a woman's risk for thin-ideal internalization may be genetic.
Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
The 2015 António Champalimaud Vision Award is given to three institutions that have developed a unique collaborative project to achieve the common goal of fighting blindness and poverty in Africa.
ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.
› Verified 1 days ago
Dr. Michael Patrick Burk, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 39555 W 10 Mile Rd, Suite 307, Novi, MI 48375 Phone: 248-476-1500 Fax: 248-476-0502 | |
Novi Foot & Ankle Specialist Podiatrist Medicare: Medicare Enrolled Practice Location: 44000 W 12 Mile Rd, Ste 111, Novi, MI 48377 Phone: 248-347-8233 | |
Dr. Robert Matthew Koivunen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 39450 W 12 Mile Rd, Novi, MI 48377 Phone: 248-344-2390 Fax: 248-344-2404 | |
Associated Podiatrists,pc Podiatrist Medicare: Medicare Enrolled Practice Location: 26750 Providence Pkwy, Suite 130, Novi, MI 48374 Phone: 248-348-5300 Fax: 248-348-5410 | |
Issam N Mansour Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 24230 Karim Blvd, Ste 140, Novi, MI 48375 Phone: 248-888-9500 Fax: 248-888-9504 | |
Dr. Neal A Mozen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 26850 Providence Pkwy Ste 502, Novi, MI 48374 Phone: 248-258-0001 Fax: 248-258-6779 | |
Ned Broder Hirsch, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 30750 Tanglewood Dr, Novi, MI 48377 Phone: 248-568-2470 |